• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种预测川崎病静脉注射免疫球蛋白抵抗的新模型:一项大型队列研究。

A novel model for predicting intravenous immunoglobulin-resistance in Kawasaki disease: a large cohort study.

作者信息

Wang Shuhui, Ding Chuxin, Zhang Qiyue, Hou Miao, Chen Ye, Huang Hongbiao, Qian Guanghui, Yang Daoping, Tang Changqing, Zheng Yiming, Huang Li, Xu Lei, Zhang Jiaying, Gao Yang, Zhuo Wenyu, Zeng Bihe, Lv Haitao

机构信息

Department of Cardiology, Children's Hospital of Soochow University, Suzhou, China.

Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou, China.

出版信息

Front Cardiovasc Med. 2023 Jul 28;10:1226592. doi: 10.3389/fcvm.2023.1226592. eCollection 2023.

DOI:10.3389/fcvm.2023.1226592
PMID:37576105
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10420135/
Abstract

BACKGROUND

Predicting intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD) can aid early treatment and prevent coronary artery lesions. A clinically consistent predictive model was developed for IVIG resistance in KD.

METHODS

In this retrospective cohort study of children diagnosed with KD from January 1, 2016 to December 31, 2021, a scoring system was constructed. A prospective model validation was performed using the dataset of children with KD diagnosed from January 1 to June 2022. The least absolute shrinkage and selection operator (LASSO) regression analysis optimally selected baseline variables. Multivariate logistic regression incorporated predictors from the LASSO regression analysis to construct the model. Using selected variables, a nomogram was developed. The calibration plot, area under the receiver operating characteristic curve (AUC), and clinical impact curve (CIC) were used to evaluate model performance.

RESULTS

Of 1975, 1,259 children (1,177 IVIG-sensitive and 82 IVIG-resistant KD) were included in the training set. Lymphocyte percentage; C-reactive protein/albumin ratio (CAR); and aspartate aminotransferase, sodium, and total bilirubin levels, were risk factors for IVIG resistance. The training set AUC was 0.825 (sensitivity, 0.723; specificity, 0.744). CIC indicated good clinical application of the nomogram.

CONCLUSION

The nomogram can well predict IVIG resistance in KD. CAR was an important marker in predicting IVIG resistance in Kawasaki disease.

摘要

背景

预测静脉注射免疫球蛋白(IVIG)抵抗性川崎病(KD)有助于早期治疗并预防冠状动脉病变。已针对KD中的IVIG抵抗性建立了一个临床一致性预测模型。

方法

在这项对2016年1月1日至2021年12月31日诊断为KD的儿童进行的回顾性队列研究中,构建了一个评分系统。使用2022年1月1日至6月诊断为KD的儿童数据集进行前瞻性模型验证。最小绝对收缩和选择算子(LASSO)回归分析最佳地选择了基线变量。多变量逻辑回归纳入了LASSO回归分析中的预测因子以构建模型。使用选定变量,绘制了列线图。校准图、受试者操作特征曲线下面积(AUC)和临床影响曲线(CIC)用于评估模型性能。

结果

在1975名儿童中,1259名儿童(1177名IVIG敏感型和82名IVIG抵抗型KD)被纳入训练集。淋巴细胞百分比;C反应蛋白/白蛋白比值(CAR);以及天冬氨酸转氨酶、钠和总胆红素水平是IVIG抵抗的危险因素。训练集AUC为0.825(敏感性,0.723;特异性,0.744)。CIC表明列线图具有良好的临床应用价值。

结论

列线图可以很好地预测KD中的IVIG抵抗性。CAR是预测川崎病IVIG抵抗性的重要标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae8/10420135/90c9a16c6f38/fcvm-10-1226592-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae8/10420135/65a53fe10c91/fcvm-10-1226592-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae8/10420135/7ea68df3e2ea/fcvm-10-1226592-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae8/10420135/067e104157f9/fcvm-10-1226592-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae8/10420135/8ca8a1b21f12/fcvm-10-1226592-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae8/10420135/d05bfcc7ba33/fcvm-10-1226592-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae8/10420135/e39f2cfb45ff/fcvm-10-1226592-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae8/10420135/9c7a8c404322/fcvm-10-1226592-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae8/10420135/90c9a16c6f38/fcvm-10-1226592-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae8/10420135/65a53fe10c91/fcvm-10-1226592-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae8/10420135/7ea68df3e2ea/fcvm-10-1226592-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae8/10420135/067e104157f9/fcvm-10-1226592-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae8/10420135/8ca8a1b21f12/fcvm-10-1226592-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae8/10420135/d05bfcc7ba33/fcvm-10-1226592-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae8/10420135/e39f2cfb45ff/fcvm-10-1226592-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae8/10420135/9c7a8c404322/fcvm-10-1226592-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae8/10420135/90c9a16c6f38/fcvm-10-1226592-g008.jpg

相似文献

1
A novel model for predicting intravenous immunoglobulin-resistance in Kawasaki disease: a large cohort study.一种预测川崎病静脉注射免疫球蛋白抵抗的新模型:一项大型队列研究。
Front Cardiovasc Med. 2023 Jul 28;10:1226592. doi: 10.3389/fcvm.2023.1226592. eCollection 2023.
2
Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China.中国东部地区住院川崎病患儿静脉注射免疫球蛋白耐药风险预测列线图
Ann Med. 2022 Dec;54(1):442-453. doi: 10.1080/07853890.2022.2031273.
3
Establishment and Validation of a Multivariate Predictive Scoring Model for Intravenous Immunoglobulin-Resistant Kawasaki Disease: A Study of Children From Two Centers in China.静脉注射免疫球蛋白抵抗性川崎病多变量预测评分模型的建立与验证:一项来自中国两个中心的儿童研究
Front Cardiovasc Med. 2022 Apr 27;9:883067. doi: 10.3389/fcvm.2022.883067. eCollection 2022.
4
Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.血清淀粉样蛋白 A 作为川崎病免疫球蛋白抵抗的生物标志物。
Ann Med. 2023;55(2):2264315. doi: 10.1080/07853890.2023.2264315. Epub 2023 Oct 23.
5
A nomogram for predicting immunoglobulin-resistant Kawasaki disease in children.用于预测儿童免疫球蛋白抵抗性川崎病的列线图。
J Int Med Res. 2023 Feb;51(2):3000605221139704. doi: 10.1177/03000605221139704.
6
Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.C反应蛋白/白蛋白比值在预测静脉注射免疫球蛋白抵抗性川崎病中的价值——来自中国多机构研究的数据
Int Immunopharmacol. 2020 Dec;89(Pt A):107037. doi: 10.1016/j.intimp.2020.107037. Epub 2020 Nov 23.
7
Development of an immunoinflammatory indicator-related dynamic nomogram based on machine learning for the prediction of intravenous immunoglobulin-resistant Kawasaki disease patients.基于机器学习的免疫炎症指标相关动态列线图的建立及其对静脉注射免疫球蛋白抵抗川崎病的预测价值
Int Immunopharmacol. 2024 Jun 15;134:112194. doi: 10.1016/j.intimp.2024.112194. Epub 2024 May 3.
8
Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study.C反应蛋白与白蛋白比值作为一大群川崎病患者初始及反复静脉注射免疫球蛋白抵抗生物标志物的预测价值:一项前瞻性队列研究
Pediatr Rheumatol Online J. 2021 Mar 12;19(1):24. doi: 10.1186/s12969-021-00517-1.
9
Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients.白蛋白对大样本川崎病患者静脉注射免疫球蛋白抵抗的预测价值。
Ital J Pediatr. 2023 Jun 25;49(1):78. doi: 10.1186/s13052-023-01482-z.
10
Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.预测儿童川崎病的静脉注射免疫球蛋白耐药性。
World J Pediatr. 2020 Dec;16(6):607-613. doi: 10.1007/s12519-020-00348-2. Epub 2020 Mar 30.

引用本文的文献

1
Association between C-reactive protein-albumin-lymphocyte (CALLY) index with intravenous immunoglobulin non-response in Kawasaki disease.川崎病中C反应蛋白-白蛋白-淋巴细胞(CALLY)指数与静脉注射免疫球蛋白无反应性之间的关联
Ann Med. 2025 Dec;57(1):2548023. doi: 10.1080/07853890.2025.2548023. Epub 2025 Aug 20.
2
Prevalence of IVIG resistance in Kawasaki disease: a systematic review and meta-analysis.川崎病中静脉注射免疫球蛋白耐药的患病率:一项系统评价和荟萃分析。
Front Pediatr. 2025 Jul 4;13:1566590. doi: 10.3389/fped.2025.1566590. eCollection 2025.
3
Establishment and validation of risk prediction model to predict intravenous immunoglobulin-resistance in Kawasaki disease based on meta-analysis of 15 cohorts.

本文引用的文献

1
Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST.川崎病静脉注射免疫球蛋白抵抗风险预测模型:使用 PROBAST 进行风险评估。
Pediatr Res. 2023 Sep;94(3):1125-1135. doi: 10.1038/s41390-023-02558-6. Epub 2023 Mar 24.
2
C-reactive Protein-to-albumin Ratio in Spinal Epidural Abscess: Association with Post-treatment Complications.C 反应蛋白-白蛋白比值与脊髓硬膜外脓肿治疗后并发症的关系。
J Am Acad Orthop Surg. 2022 Sep 1;30(17):851-857. doi: 10.5435/JAAOS-D-22-00172. Epub 2022 May 6.
3
Predictive role of sampling-time specific prognostic nutritional index cut-off values for intravenous immunoglobulin resistance and cardiovascular complications in Kawasaki disease.
基于15个队列的荟萃分析建立和验证预测川崎病静脉注射免疫球蛋白抵抗的风险预测模型
Ital J Pediatr. 2025 Feb 21;51(1):55. doi: 10.1186/s13052-025-01889-w.
4
Nutrition-Associated Biomarkers in Predicting Intravenous Immunoglobulin Resistance and Coronary Artery Lesions in Kawasaki Disease: A Systematic Review and Meta-Analysis.营养相关生物标志物在预测川崎病静脉注射免疫球蛋白抵抗和冠状动脉病变中的作用:一项系统评价和荟萃分析
Food Sci Nutr. 2024 Dec 15;13(1):e4647. doi: 10.1002/fsn3.4647. eCollection 2025 Jan.
5
Role of Pyroptosis in IVIG-Resistant Kawasaki Disease and the Establishment of a New Predictive Model.细胞焦亡在静脉注射免疫球蛋白抵抗性川崎病中的作用及新预测模型的建立
J Inflamm Res. 2024 Dec 13;17:10999-11008. doi: 10.2147/JIR.S490095. eCollection 2024.
6
Knowledge framework of intravenous immunoglobulin resistance in the field of Kawasaki disease: A bibliometric analysis (1997-2023).川崎病静脉注射免疫球蛋白耐药领域的知识框架:文献计量分析(1997-2023)。
Immun Inflamm Dis. 2024 May;12(5):e1277. doi: 10.1002/iid3.1277.
7
C-reactive protein to albumin ratio as a prognostic tool for predicting intravenous immunoglobulin resistance in children with kawasaki disease: a systematic review of cohort studies.C-反应蛋白与白蛋白比值作为预测川崎病患儿静脉注射免疫球蛋白抵抗的预后工具:队列研究的系统评价。
Pediatr Rheumatol Online J. 2024 Apr 12;22(1):42. doi: 10.1186/s12969-024-00980-6.
特定采样时间的预后营养指数截断值对川崎病静脉注射免疫球蛋白抵抗和心血管并发症的预测作用。
Int Immunopharmacol. 2022 Sep;110:108986. doi: 10.1016/j.intimp.2022.108986. Epub 2022 Jun 25.
4
C-Reactive Protein to Albumin Ratio in Patients Undergoing Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术患者的 C 反应蛋白与白蛋白比值。
Mayo Clin Proc. 2022 May;97(5):931-940. doi: 10.1016/j.mayocp.2021.11.022. Epub 2022 Apr 9.
5
Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China.中国东部地区住院川崎病患儿静脉注射免疫球蛋白耐药风险预测列线图
Ann Med. 2022 Dec;54(1):442-453. doi: 10.1080/07853890.2022.2031273.
6
Predictive Value of the Systemic Immune-Inflammation Index for Intravenous Immunoglobulin Resistance and Cardiovascular Complications in Kawasaki Disease.全身免疫炎症指数对川崎病静脉注射免疫球蛋白抵抗及心血管并发症的预测价值
Front Cardiovasc Med. 2021 Aug 24;8:711007. doi: 10.3389/fcvm.2021.711007. eCollection 2021.
7
Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients.C 反应蛋白/白蛋白比值对高血压合并 COVID-19 患者的预后价值。
Clin Exp Hypertens. 2021 Oct 3;43(7):683-689. doi: 10.1080/10641963.2021.1937205. Epub 2021 Jul 5.
8
Sodium-containing versus sodium-trace preparations of IVIG for children with Kawasaki disease in the acute phase.含钠与微量钠静脉注射免疫球蛋白制剂治疗川崎病急性期儿童的比较。
Eur J Pediatr. 2021 Nov;180(11):3279-3286. doi: 10.1007/s00431-021-04096-x. Epub 2021 May 10.
9
Comparison of risk scores for predicting intravenous immunoglobulin resistance in Taiwanese patients with Kawasaki disease.比较风险评分预测台湾川崎病患者静脉注射免疫球蛋白耐药的效果。
J Formos Med Assoc. 2021 Oct;120(10):1884-1889. doi: 10.1016/j.jfma.2020.12.010. Epub 2020 Dec 23.
10
C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease.C反应蛋白与白蛋白比值对预测川崎病冠状动脉病变及静脉注射免疫球蛋白抵抗的作用
Front Pediatr. 2020 Nov 25;8:607631. doi: 10.3389/fped.2020.607631. eCollection 2020.